These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5923165)

  • 21. L1210 leukemia hybrids isolated after fusion of alkylating agent-resistant sublines.
    Schmid FA; Otter GM; Hirano I
    Leuk Res; 1988; 12(1):67-70. PubMed ID: 3357349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observations on viral, chemical, and radiation-induced myeloid and lymphoid leukemias in RF mice.
    Upton AC; Jenkins VK; Walburg HE; Tyndall RL; Conklin JW; Wald N
    Natl Cancer Inst Monogr; 1966 Sep; 22():329-47. PubMed ID: 5223940
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of methotrexate resistance by genistein in murine leukemia L1210 cells.
    Xuan Y; Hacker MP; Tritton TR; Bhushan A
    Oncol Rep; 1998; 5(2):419-21. PubMed ID: 9468571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) with nucleic acids and proteins in vivo and in vitro.
    Cheng CJ; Fujimura S; Grunberger D; Weinstein IB
    Cancer Res; 1972 Jan; 32(1):22-7. PubMed ID: 5007685
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of methotrexate on 5-phosphoribosyl 1-pyrophosphate levels in L1210 leukemia cells in vitro.
    Buesa-Perez JM; Leyva A; Pinedo HM
    Cancer Res; 1980 Jan; 40(1):139-44. PubMed ID: 6243086
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of methotrexate on oxygen consumption of L1210 cells and their isolated mitochondria].
    Kouamouo J; Trentesaux C; Desoize B; Carpentier Y; Jardillier JC
    C R Seances Acad Sci III; 1981 Feb; 292(7):485-90. PubMed ID: 6786782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute toxicity of methotrexate and cyclophosphamide in mice inoculated with malignant neoplasms.
    Graczyk J
    Pol J Pharmacol Pharm; 1981; 33(1):73-80. PubMed ID: 7255281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chemotherapeutic agents on normal mouse bone marrow grown in vitro.
    Brown CH; Carbone PP
    Cancer Res; 1971 Feb; 31(2):185-90. PubMed ID: 5545269
    [No Abstract]   [Full Text] [Related]  

  • 29. Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cells.
    Gangji D; Ross WE; Bleyer WA; Poplack DG; Glaubiger DL
    Cancer Treat Rep; 1984 Mar; 68(3):521-5. PubMed ID: 6704981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of the sequence of administration of cytoxan and methotrexate on the life-span of L1210 leukemic mice.
    Straus MJ; Mantel N; Goldin A
    Cancer Res; 1972 Feb; 32(2):200-7. PubMed ID: 5058180
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
    Wheeler GP; Adamson DJ; Webster J
    Cancer Res; 1985 Jul; 45(7):3400-2. PubMed ID: 4005864
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological immunosuppressive agents.
    Salaman JR
    Ulster Med J; 1981; 50(Suppl 1):36-42. PubMed ID: 7015656
    [No Abstract]   [Full Text] [Related]  

  • 33. Informal discussion: experimental basis for the chemical eradication of leukemia.
    Frei E
    Cancer Res; 1967 Dec; 27(12):2656-7. PubMed ID: 6082303
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice.
    Abraham D; Carbone PP; Venditti JM; Kline I; Goldin A
    Biochem Pharmacol; 1967 Apr; 16(4):665-73. PubMed ID: 6033787
    [No Abstract]   [Full Text] [Related]  

  • 35. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of alkylating agents and other drugs on the accumulation of melphalan by murine L1210 leukaemia cells in vitro.
    Martin AD; Beer RW; Bosanquet AG; Gilby ED
    Biochem Pharmacol; 1982 Sep; 31(17):2727-32. PubMed ID: 7138568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of alkylants, antimetabolites and chloroquine on oxydative biotransformation reactions and on the excretion of ascorbic acid in the rat.
    Traeger A; Bauer B; Klinger W; Ankermann H
    Acta Biol Med Ger; 1973; 30(3):423-34. PubMed ID: 4800889
    [No Abstract]   [Full Text] [Related]  

  • 38. On the nature of a transport alteration determining resistance to amethopterin in the L1210 leukemia.
    Sirotnak FM; Kurita S; Hutchison DJ
    Cancer Res; 1968 Jan; 28(1):75-80. PubMed ID: 5635374
    [No Abstract]   [Full Text] [Related]  

  • 39. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
    Klubes P; Cerna I
    Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHEMOTHERAPEUTIC EFFECTS ON MAMMALIAN TUMOR CELLS. I. MODIFICATION OF LEUKEMIA L1210 GROWTH KINETICS AND KARYOTYPE WITH AN ALKYLATING AGENT.
    JOHNSON RE; ZELEN M; KEMP NH
    J Natl Cancer Inst; 1965 Feb; 34():277-90. PubMed ID: 14293793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.